Education
About Us
Working with TipRanks
Follow Us
Qyuns Therapeutics Co., Ltd. Class H (HK:2509)
:2509
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | ¥ 158.79M | ¥ 14.75M | ¥ 9.66M | ¥ 21.35M |
| Gross Profit | ¥ 92.19M | ¥ 14.75M | ¥ -25.85M | ¥ -9.56M |
| Operating Income | ¥ -326.37M | ¥ -504.51M | ¥ -293.69M | ¥ -168.62M |
| EBITDA | ¥ -311.82M | ¥ -484.12M | ¥ -295.51M | ¥ -155.65M |
| Net Income | ¥ -335.57M | ¥ -507.75M | ¥ -298.19M | ¥ -411.04M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | ¥ 556.55M | ¥ 377.25M | ¥ 689.57M | ¥ 620.44M |
| Total Assets | ¥ 983.88M | ¥ 795.58M | ¥ 1.16B | ¥ 1.31B |
| Total Debt | ¥ 527.60M | ¥ 346.06M | ¥ 295.25M | ¥ 290.26M |
| Net Debt | ¥ 166.91M | ¥ 129.76M | ¥ 92.25M | ¥ 88.33M |
| Total Liabilities | ¥ 762.83M | ¥ 494.63M | ¥ 419.55M | ¥ 444.45M |
| Stockholders' Equity | ¥ 228.98M | ¥ 324.54M | ¥ 641.72M | ¥ 670.35M |
| Cash Flow | ||||
| Free Cash Flow | ¥ -186.09M | ¥ -308.63M | ¥ -301.70M | ¥ -228.64M |
| Operating Cash Flow | ¥ -186.09M | ¥ -300.68M | ¥ -275.23M | ¥ -157.60M |
| Investing Cash Flow | ¥ -25.23M | ¥ 243.11M | ¥ -5.70M | ¥ -306.69M |
| Financing Cash Flow | ¥ 351.81M | ¥ 61.21M | ¥ 211.49M | ¥ 281.48M |